Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 4.01, 9.01 · 8-K

Allurion Technologies, Inc.

Changes in Registrant's Certifying Accountant

Item 4.01 Changes in Registrant’s Certifying Accountant. Dismissal of Independent Registered Public Accounting Firm Deloitte & Touche LLP (“Deloitte”) has served as the independent registered public accounting firm for Allurion Technologies, Inc. (the “Company”) since 2016. On May 22, 2026 (the “Effective Date”), Deloitte was dismissed as our independent registered public accounting firm.…

Filed May 27, 2026Accepted May 27, 2026, 4:35 PM EDTCIK 1964979Accession 0001193125-26-242009
Share

Company context

Allurion is a pioneer in metabolically healthy weight loss. The Allurion Program is a weight-loss platform that combines the Allurion Smart Capsule, the world’s first and only swallowable, ProcedurelessTM gastric balloon for weight loss, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor, and manage weight-loss therapy for patients regardless of their treatment plan. The Allurion Smart Capsule is an investigational device in the United States.

Current securities

Historical securities (4)

Recent company filings

  1. 25-NSE - filed by NEW YORK STOCK EXCHANGE LLC regarding ALLURION TECHNOLOGIES, INC.Oct 13, 2026
  2. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsAug 24, 2026
  3. NT 10-Q filingAug 14, 2026
  4. Entry into a Material Definitive Agreement · Termination of a Material Definitive Agreement · Unregistered Sales of Equity SecuritiesJul 24, 2026
  5. 4 filingJul 23, 2026

Registered securities in this filing

Allurion Technologies, Inc. · 8-K · Filed 2026-05-27

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common stock, par value $0.0001 per share

Symbol
ALUR
Exchange
NONE
Classification
COMMON
Filing context

Context: C_d4755fa5-d262-4105-acdc-6d07dd3aabd8

Dimensions: us-gaap:StatementClassOfStockAxis

Warrants to purchase 0.056818 shares of common stock, each at an exercise price of $202.50 per share of common stock

Symbol
ALUR WS
Exchange
NONE
Classification
WARRANT
Filing context

Context: C_41f79fe5-2aef-4afc-8a7a-157fdf10ba37

Dimensions: us-gaap:StatementClassOfStockAxis

Accession 000119312526242009 · 2 registered-security cover members

Read the exact SEC filing ↗

Disclosure sections

Items 4.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 4.01Item 4.01 - Changes in Certifying Accountant
Item 4.01 Changes in Registrant’s Certifying Accountant. Dismissal of Independent Registered Public Accounting Firm Deloitte & Touche LLP (“Deloitte”) has served as the independent registered public accounting firm for Allurion Technologies, Inc. (the “Company”) since 2016. On May 22, 2026 (the “Effective Date”), Deloitte was dismissed as our independent registered public accounting firm. The decision to dismiss Deloitte was approved by the Audit Committee of the Board of Directors (the “Audit Committee”) of the Company. The reports of Deloitte on our consolidated financial statements for the fiscal years ended December 31, 2025 and 2024 did not contain an adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles. During our two most recent fiscal years and the subsequent period from January 1, 2026 to May 22, 2026, there were (i) no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions thereto) with Deloitte on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreement, if not resolved to the satisfaction of Deloitte, would have caused it to make reference to the subject matter of the disagreement in connection with its report and (ii) no reportable events (as described in Item 304(a)(1)(v) of Regulation S-K), except for the existence of material weaknesses in internal control over financial reporting for fiscal years ended December 31, 2024 and 2025 and the interim period ended May 22, 2026 relating to (a) insufficient segregation of duties in the financial statement close process; (b) a lack of sufficient levels of staff with public company and technical accounting experience to maintain proper control activities and perform risk assessment and monitoring activities and (c) insufficient information systems controls, including access and change management controls, as previously disclosed in our annual and periodic filings with the Securities and Exchange Commission (“SEC”) during these periods. We provided Deloitte with a copy of the disclosures made in this Item 4.01 and requested Deloitte to furnish us with a letter addressed to the SEC, stating whether it agrees with the statements made by us and, if not, stating the respects in which it does not agree. A copy of Deloitte’s letter to the SEC dated May 27, 2026 regarding these statements is filed as Exhibit 16.1 to this Current Report on Form 8-K. Appointment of New Independent Registered Public Accounting Firm On May 20, 2026, the Audit Committee appointed CBIZ CPAs P.C. (“CBIZ”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, effective as of May 20, 2026. During our two most recent fiscal years and the subsequent period from January 1, 2026 to May 22, 2026, we did not consult with CBIZ regarding any of the matters or events set forth in Item 304(a)(2)(i) and (ii) of Regulation S-K.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.